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Purpose. To report the incidence and risk factors for postkeratoplasty glaucoma (PKG), as well as its management. Subjects and
Methods. 122 eyes, (43% with pseudophakic and aphakic bullous keratopathy (PABK)) which underwent penetrating keratoplasty
(PK), were analyzed. Results. The rate of PKG development was 34% within 39 months of follow-up. PABK, corneal perforations,
keratitis, and previous high intraocular pressure (PHIOP) were high risk factors for PKG. Glaucoma was controlled medically in
62% of PKG cases. Surgery (Ex-PRESS shunt in 63%) and diode laser cyclophotocoagulation were applied in others (38%). The
rate of postoperative complications and graft survival was similar in eyes with and without PKG. Conclusion.P H I O P ,p r e o p e r a t i v e
diagnoses other than keratoconus, and corneal dystrophies were highly associated with PKG. Ex-PRESS shunts were eﬀective in
refractory PKG. If glaucoma is controlled, it is possible to obtain similar rates of graft survival and postoperative complications in
eyes with and without PKG.
1.Introduction
There are many corneal transplantation techniques such as
deep anterior lamellar keratoplasty and Descemet’s stripping
endothelial keratoplasty with many advantages over pen-
etrating keratoplasty (PK), but PK is still the most com-
mon type of corneal transplant performed [1]. The leading
indications for PK are keratoconus, bullous keratopathy
(BK), corneal scars due to previous intraocular surgeries,
infections, or trauma, corneal dystrophies, and graft fail-
ure [2]. In developing countries, corneal scars due to
herpes simplex virus, presumed bacterial infections, or
traumatic insults are more frequent indications for PK than
the noninﬂammatory conditions such as keratoconus and
corneal dystrophies [3]. The success of PK depends on
manypreoperative,intraoperative,andpostoperativefactors,
including the health of the donor cornea, the indication for
PK, suture techniques preferred, the quality of postoperative
management, and the presence of high intraocular pressure
(IOP) [1]. Postkeratoplasty glaucoma (PKG) is one of the
challengingissuesimportantforthesurvivalofthegraft.The
incidenceofPKGhasbeenreportedtorangebetween9%and
35% [4–9]. It has been reported to be one of the most serious
complications following PK and the second leading cause
of graft failure after graft rejection [10, 11]. Its diagnosis
and management are much more diﬃcult than the glaucoma
cases with their own corneas [12].
The aims of our study were to report the incidence and
risk factors for PKG and its management.
2.MaterialsandMethods
This was a retrospective study conducted at the Department
of Ophthalmology, Eskisehir Osmangazi University Medical
Faculty, Eskisehir, Turkey. The charts of 155 eyes that
underwent PK between January 2007 and July 2010 were
reviewed independently from the indication for PK. Out
of these 155 eyes, 122 satisﬁed all the inclusion criteria.
The inclusion criteria were follow-up period of at least 12
months after PK and well-documented IOP measurements
at each visit. These 122 eyes were allocated to three groups
depending on the indications for PK. Group 1 included 292 Journal of Ophthalmology
Table 1: Indications for penetrating keratoplasty.
Indications Number of eyes Percentage
Group 1 Keratoconus 17 14%
Corneal dystrophies 12 10%
Group 2 Pseudophakic/aphakic bullous keratopathy 53 43%
Group 3
Herpes simplex keratitis 7 6%
Corneal scars due to corneal perforation 9 7%
Corneal scars due to presumed infections 13 10.5%
Corneal graft failure 6 5%
Silicon keratopathy 3 2.5%
Spontaneous corneal perforation 2 2%
Table 2: The number of eyes that underwent additional procedures
during penetrating keratoplasty.
Group 1 Group 2 Group 3
Anterior vitrectomy 0 3 2
Synechiolysis 0 4 6
Pupilloplasty 0 1 2
Cataract surgery 2 0 9
Intraocular lens exchange 0 3 1
Intraocular lens extraction 0 3 1
eyes of 24 patients (16 women and 8 men) with keratoconus
or corneal dystrophies. Group 2 included 53 eyes of 51
patients (28 women and 23 men) with pseudophakic or
aphakik BK. Group 3 included 40 eyes of 40 patients (20
women and 20 men) with indications other than those in
groups 1 and 2. Indications for PK are represented in Table 1.
PKG was deﬁned as the persistence of raised IOP
(>21mmHg) or the requirement for increased treatment in
patients with previous high intraocular pressure (PHIOP),
one month after PK, in the presence of glaucomatous optic
disc changes. All the procedures, namely, PK, glaucoma
surgeries, and diode laser cyclophotocoagulation (DCPC),
wereperformedbyanexperiencedophthalmologist(NY).97
PK cases were performed under general anesthesia and the
remaining under retrobulbar anesthesia. Standard surgical
techniquewasused.Themeandiameterofthedonorcorneal
button was 8.0mm (range, 7.5–8.5mm), and the mean
diameteroftherecipientbedwas0.5mmto0.25mmsmaller
than the donor corneal bed. Single continuous suture was
preferredinmostofthecases.Inhighlyvascularizedcorneas,
interrupted sutures were used. Additional procedures during
PK were performed on an individual basis (Table 2). PK
and cataract surgery combined with intraocular lens (IOL)
implantation were performed in eleven eyes, and in two of
these, PKG developed. Phacoemulsiﬁcation (Phaco) and in-
the-bag posterior chamber IOL (PCIOL) implantation were
performed in four of these through the diseased cornea
and open-sky extracapsular cataract extraction (ECCE) in
the other seven. In the four cases that underwent ECCE
surgery, PCIOL was implanted in the ciliary sulcus, and
no IOL was implanted in the other three. Phaco and
in-the-bag PCIOL implantation were performed in six eyes
during the follow-up. Hydrophobic acrylic foldable IOL was
inserted in the bag and poly(methyl methacrylate) (PMMA)
IOL was preferred in the ciliary sulcus. IOL exchange or
extraction was performed during PK in eight cases. Iris-claw
lens (Ophtec) was implanted in these eight cases.
Topical antibiotic eye drops four times/day for one
month and topical prednisolone phosphate (0.5%) eye drops
four times/day for up to one year, with gradually tapering
doses, were routinely applied in all cases. Topical and/or
systemic steroids in higher doses were applied if anterior
segment inﬂammation and/or graft rejection occurred.
Topicalbeta-blockers,carbonicanhydraseinhibitors,and
alpha-2 agonist were initiated in PKG cases. In PKG cases
refractory to medical treatment, trabeculectomy, the Ex-
PRESS shunt (with 50 micron lumen) implantation, the
Ahmed glaucoma valve (AGV) implantation, or DCPC were
performed under retrobulbar anesthesia. 5-Fluorouracil was
applied intraoperatively in the trabeculectomy and Ex-
PRESS shunt implantation. The Ex-PRESS shunts were
implanted under partial-thickness scleral ﬂap. AGV was
implanted in the superotemporal quadrant beneath the
sub-Tenons’s space. The subconjunctival and sub-Tenons’s
portion of the tube was covered with a patch graft of
donor dura matter. An informed consent was obtained from
all subjects before surgery. The Tenets of the Declaration
of Helsinki were followed, and the local medical ethics
committee approved the study.
All patients were followed up postoperatively with rou-
tine ophthalmic examinations at the ﬁrst day, ﬁrst week,
ﬁrst month, the third month, the sixth month, and every
six months thereafter. The best-corrected visual acuities
(BCVAs) in logMAR units and IOP pressure were assessed
preoperatively and postoperatively at each visit. The BCVAs
at the ﬁnal visit were used for statistical and clinical analyses.
For data analysis in the study, 2.2 logMAR, 2.3 logMAR, and
2.4 logMAR were used instead of hand movement (HM),
perception of light (PL), and no perception of light (NPL),
respectively. The IOP was measured using the Tono-Pen. The
indicationsforPK,thepresenceofPHIOP,andthelensstatus
were noted. The anterior segment examination was per-
formed at each visit. The management modalities for PKG,
the IOP before the initiation of glaucoma treatment, the IOP
at the ﬁnal visits, and the number of antiglaucomatous drugsJournal of Ophthalmology 3
Table 3: The number of eyes (%) with previous high intraocular pressure (PHIOP) and post-keratoplasty glaucoma (PKG) and the PKG
cases requiring medical or surgical treatment according to the indications of penetrating keratoplasty.
Group 1 Group 2 Group 3
Follow-up time (months) 39.0 ±10.94 2 .7 ±13.23 3 .6 ±13.9
Age (years) 44.8 ±16.96 6 .8 ±11.95 6 .5 ±19.6
PHIOP (%) 1/29 (3%) 13/53 (25%) 3/40 (8%)
Post-keratoplasty glaucoma (%) 6/29 (20%) 19/53 (36%) 17/40 (42%)
Medically treated PKG cases 5 10 11
Surgically treated PKG cases 1 8 5
Diode-laser-applied cases 0 2 1
Table 4:Oddsratioand95%conﬁdenceintervalfrombinomialregressionofthelikelihoodofdevelopingpost-keratoplastyglaucoma(PKG)
(versus without PKG) on indications for penetrating keratoplasty (PK), the lens status, and previous high intraocular pressure (PHIOP).
Univariate binomial logistic regression analysis
Variables Odds ratio 95% conﬁdence interval
Indications for PK
Group 1 1
Group 2 2.1 0.7–6.2
Group 3 2.8 0.9–8.4
Lens status
Phakic 1
Aphakia before PK 2.1 0.7–6.6
Pseudophakia before PK 2.6 0.9–7.3
Combined cataract surgery 1.3 0.3–6.4
Cataract surgery after PK 2.4 0.4–17.2
PHIOP Nonexisting 1
Existing 8.5 2.6–28.3
applied were documented. Eyes were evaluated regarding the
incidence and risk factors for developing PKG.
The IOP before treatment was compared with IOP after
treatment in medically and surgically treated cases separately
using paired samples t-test. Odds ratios and 95% conﬁdence
intervals were calculated to determine the probability of
developing PKG, using logistic regression analysis with PKG
as the dependent variable, and the indications for PK,
the lens status, and the PHIOP as independent variables.
The incidence of graft rejection, graft failure, and post-
keratoplastyinfectionsincaseswithPKGwascomparedwith
that without PKG using Yates’ chi-square test. P value < 0.05
was required for statistical signiﬁcance. Statistical analyses
were performed using SPSS version 15.0 (SPSS Inc., Chicago,
Ill, USA).
3. Results
122 eyes of 115 patients were reviewed. PKG developed in 42
(34%) of these eyes within 38.9 ± 14.3 (12–72) months of
follow-up.
The mean preoperative and postoperative BCVA in eyes
with PKG were 2.12 ± 0.25 and 1.6 ± 0.71 logMAR units,
respectively (P = 0.001). The mean pre-operative and post-
operative BCVA in eyes without PKG were 2.13 ± 0.16 and
1.17 ± 0.85 logMAR units, respectively (P = 0.001). The
visual acuity was improved in 33/42 (79%) of the eyes with
PKG and 64/80 (80%) of the eyes without PKG (P>0.05).
The number of eyes with PHIOP, post-keratoplasty
glaucoma (PKG) and the PKG cases requiring medical or
surgical treatment according to the indications of PK are
represented in Table 3. Seventeen eyes (one in group 1,
thirteen in group 2, and three in group 3) had a PHIOP.
IOP was ≤21 mmHG with medication prior to PK in these
seventeen eyes, but in thirteen of these PKG developed. In
seven out of these thirteen, IOP was not controlled despite
increased medication and glaucoma surgery was performed.
The indications for PK other than keratoconus and
corneal dystrophies, previous pseudophacia and aphakia,
cataract surgery after PK, and PHIOP were highly associated
with PKG (P<0.05) (Table 4). Pseudophakia (including 36
posterior and ten anterior chamber IOL) prior to PK was
present in 46 eyes and aphakia prior to PK in 26 eyes.
Pre- and posttreatment IOP values in medically and
s u r g i c a l l yt r e a t e de y e sa r er e p r e s e n t e di nT a b l e s5 and 6.I O P
was >21 mmHG despite medical and surgical treatments
in one case, in which trabeculectomy and DCPC were
performed.
The mean time interval between the diagnosis of PKG
andPKwas12.8±8.9(2–36)months.SixteenPKGcaseswere
refractory to antiglaucomatous drugs. The AGV implanta-
tion was performed in three of these, the Ex-PRESS mini
glaucoma shunt implantation in ten of these, and DCPC in4 Journal of Ophthalmology
Table 5: The mean pre- and posttreatment intraocular pressures (IOPs) in mmHg.
Number of cases Pretreatment IOP Posttreatment IOP P value
Medically treated cases 26 26.9 ±3.01 5 .9 ±1.8 0.001
Surgically treated cases including
diode laser applications 16 29.5 ±4.71 4 .2 ±4.1 0.001
Table 6: The management of refractory post-keratoplasty glaucoma cases. The mean intraocular pressures (IOPs) in mmHg, the mean
number of antiglaucomatous drugs before and after treatment.
Number of cases IOP before IOP after Drugs Number of
before
Drugs Number of
after
Trabeculectomy 1 36 18 3 2
Ex-PRESS shunt 10 28.9 ±5.31 2 .9 ±3.12 .6 ±0.80 .8 ±1.1
AGV implant 3 29 15 3 2
Diode laser 3 32 17 3 2
AGV: Ahmed glaucoma valve.
Table 7: Incidence of graft rejection, graft failure, and post-
keratoplasty infections in cases with post-keratoplasty glaucoma
(PKG) versus in cases without PKG.
With PKG Without PKG P
value
Graft rejection 7/42 (17%) 13/80 (16%) 0.9
Graft failure 7/42 (17%) 13/80 (16%) 0.9
Post-keratoplasty infections 4/42 (10%) 8/80 (10%) 0.9
two of these. DCPC was performed three months following
trabeculectomy in one case (Table 6).
Corneal graft rejection occurred in seven out of 42 PKG
eyes and thirteen out of 80 eyes without PKG. Corneal graft
failure developed in six out of these twenty cases in which
rejection occurred. Fourteen cases responded to medical
treatment.
Corneal graft failure developed in twenty cases. Post-
keratoplasty infections were responsible for failures in nine
cases. The risk for developing corneal graft rejections,
corneal graft failures, or infections following PK was similar
in patients with and without PKG (Table 7). Regraft was
performed in nine eyes.
4. Discussion
In the present study, the incidence of PKG was found to be
34% with 39 months of follow-up. Most of the PKG cases
were diagnosed within a year following PK. Simmons et al.
also reported an incidence of 34% of PKG following PK [9].
The mean time interval from PK to diagnosis of PKG was 24
weeks.Theten-yearcumulativeriskofPKGfollowingPKwas
found to be 21% by Ing et al. [10]. The incidence of PKG was
reported to be lower in the early post-operative period, but
if long-term follow-up had be a possible, the rate probably
would have increased [4, 5, 9].
The diagnosis of PKG is a challenging process due
to diﬃculties in the measurement of IOP in the corneal
graft and the possible occurrence of steroid-induced IOP
elevations in the post-operative period [13, 14]. The Tono-
Pen is the most accurate commercially available instrument
for measurement of IOP in the early post-operative period,
so the Tono-Pen was preferred in the present study [15]. The
diagnosis of PKG was made if IOP rise persisted after one
month following PK in the presence of glaucomatous optic
discchanges.TemporaryIOPelevationsduetoinﬂammatory
processes can occur in the early post-operative period, and
this can interfere with the diagnosis of PKG. In addition to
this, the corneal edema, which is frequently observed in the
early post-operative period, resolves after the ﬁrst month,
so that the IOP measurements are more accurate after one
month from PK.
It has been reported that the incidence PKG is associated
with the indications for PK [7]. Patients with pseudophakic
BK, corneal perforation, and graft rejection were shown
to be at high risk for PKG. Our ﬁndings were consistent
with the previous studies [9, 16, 17]. In the present study,
PKG developed in 20% of the patients with keratoconus or
cornealdystrophies.TherewasonlyonePKcaserefractoryto
medical treatment in the keratoconus and corneal dystrophy
group. The ratio was higher with other corneal pathologies
such as pseudophakik BK, corneal perforations, and herpes
keratitis. However, nine out of nineteen (47%) PK cases that
developed in BK cases and six out of seventeen PK cases that
developed in group 3 did not respond to antiglaucomatous
drugs.
In the present study pseudophakia and aphakia prior to
PK and combined surgery (phaco and IOL implantation)
during the follow-up after PK were found to be the risk
factors for PKG. The majority of the pseudophakic and
aphakiccaseswerehavingBK,soitisnotpossibletoconsider
pseudophakia and aphakia as independent risk factors.
Inﬂammatory processes associated with the surgery, the IOL
material, the peripheral anterior synechia formation, and the
eﬀects of aphakia and pseudophakia on the angle structures
are the most probable explanations for the increased PK
incidence in these cases [8, 9, 18].Journal of Ophthalmology 5
In thirteen (76%) of the cases with PHIOP, PKG devel-
oped. In seven of these cases, glaucoma surgery was per-
formed to lower the IOP, whereas antiglaucomatous drugs
were eﬀective in the other six. The ﬁnding was consistent
with the previous studies in which PHIOP was shown to be a
major risk factor for PKG [19].
Sixteen PKG cases (38%) were refractory to medical
treatment, and trabeculectomy AGV implantation, Ex-
PRESS mini glaucoma shunt implantation, and DCPC were
performed in these. In all of the cases, except one, IOP
was controlled with the surgical interventions. The AGV
implantation was shown to be associated with graft failure
due to tube-corneal endothelium touch and the instability of
the tube in several studies [20]. The Ex-PRESS mini glau-
coma shunt implantation was the most preferred surgical
procedure (62%) in our study. It was successfully implanted
in ten cases lowering mean IOP from 29 to 13mmHg. It is
a small nonvalved device that is very stable in the anterior
chamber [21]. The eﬃcacy of the device has been reported to
be similar with trabeculectomy in healthy corneas [21]. Ates
et al. achieved success rate of 93% with the Ex-PRESS shunt
inPKGcases[22].TheEx-PRESSshuntmaybeanalternative
treatment in PKG cases resistant to medical treatment. It
has many advantages over trabeculectomy and conventional
glaucoma drainage devices. First, it is a simple and less
invasive procedure compared to trabeculectomy. Second the
risk of intraoperative and postoperative inﬂammation and
c o m p l i c a t i o n si sl o w[ 21]. Finally the risk of endothelial cell
loss associated with AGV implant is negligible with the Ex-
PRESS shunt [21].
Inadequate control of IOP after PK is an important
cause of graft failure [23]. In the present study, the IOP
of ≤21mmHg was obtained by medical treatment, surgical
treatment, or DCPC in the majority of the PKG cases. The
rates of post-operative complications including graft rejec-
tion episodes, graft failures, and post-keratoplasty infections
were similar in patients with and without PKG. The success
rate of visual acuity improvement was the same in patients
with and without PKG.
There are some limitations of the current study. The
numberofeyesthatunderwentPKduetonon-inﬂammatory
conditions (keratoconus and corneal dystrophies) was much
less than the eyes that underwent PK due to other patholo-
gies. Pseudophakik and aphakik BK comprised 43% of
the study group, whereas the noninﬂammatory conditions
comprised 24% of the study group. There are several expla-
nations for the lower percentage of the non-inﬂammatory
conditions in the present study. First, this retrospective study
was conducted at our ophthalmology department, which
is considered to be one of the national referral centers for
corneal diseases, so many complicated cases including BK
and corneal perforations have been referred to our clinic.
Second, the patient satisfaction after PK in the eyes with
the non-inﬂammatory conditions is usually higher than that
after PK in eyes with inﬂammatory conditions, such as
BK, keratitis, and corneal perforations. Therefore, there are
many patients who fail to attend their appointment after a
successful PK, and this aﬀected the distribution of the pre-
operative diagnoses in the present study. The distribution
of the pre-operative diagnosis caused overestimation of the
incidence of PKG, since BK was one of the high risk factors
for the development of PKG. The graft failure was also
overestimated.Inastudyincluding3640eyesthatunderwent
PK for the ﬁrst time, the survival of grafts was reported to be
90% at ﬁve years. The highest survival rate was documented
in grafts for eyes with non-inﬂammatory conditions and
the lowest in grafts for eyes with BK, being 70% at ﬁve
years [24].Thesmallnumberofeyeswithnon-inﬂammatory
conditions in the current study was the possible explanation
for the high incidence of graft failure after a mean follow-up
of 39 months. The incidence of post-keratoplasty infections
w a s1 0 %i nt h ep r e s e n ts t u d y .I tw a sr e p o r t e dt or a n g e
from 2% to 12% of eyes undergoing PK [25–27]. The large
percentage of eyes undergoing PK due to inﬂammatory
conditions (76%) may explain the high incidence of post-
keratoplasty infections.
In conclusion, PKG developed in one out of three
patients who underwent PK. PHIOP, pseudophakik BK,
pseudophakia, aphakia, corneal perforations, and corneal
scars were highly associated with PKG, whereas PKG was
less likely to develop in cases with keratoconus and corneal
dystrophies. In PKG cases refractory to medical treatment,
variable glaucoma surgeries and DCPC may be applied.
The Ex-PRESS shunt implantation may be the ﬁrst-choice
surgical procedure for refractory PKG. If IOP is adequately
controlled in PKG, it may be possible to obtain similar rates
of graft survival and post-operative complications in eyes
with and without PKG.
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